Harnessing Digital Medicine to Improve Allergic Rhinitis Management in Primary Care (DMAR)

NANot yet recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

January 30, 2026

Conditions
Allergic RhinitisSinusitis
Interventions
OTHER

QHSLab Digital Tools (AME and ARIS)

Participants will use the QHSLab digital platform, which includes two tools: the Allergy Management Evaluation (AME) and the Allergic Rhinitis Intervention Steps (ARIS). The AME provides a comprehensive digital assessment for identifying and monitoring allergic rhinitis symptoms. The ARIS offers personalized feedback based on patient-reported outcomes and continuously adjusts treatment recommendations through an algorithm. These tools support better symptom management, adherence to medication, and overall improvement in quality of life.

Trial Locations (1)

33407

QHSLab, West Palm Beach

All Listed Sponsors
lead

QHSLab, Inc.

INDUSTRY

NCT06603935 - Harnessing Digital Medicine to Improve Allergic Rhinitis Management in Primary Care (DMAR) | Biotech Hunter | Biotech Hunter